A new trading day began on Monday, with Phathom Pharmaceuticals Inc (NASDAQ: PHAT) stock price down -3.91% from the previous day of trading, before settling in for the closing price of $11.51. PHAT’s price has ranged from $6.07 to $17.02 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -27.79%. With a float of $27.76 million, this company’s outstanding shares have now reached $57.97 million.
In an organization with 452 employees, it is important to assess its efficiency.
Phathom Pharmaceuticals Inc (PHAT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Phathom Pharmaceuticals Inc is 52.58%, while institutional ownership is 48.31%. The most recent insider transaction that took place on Jul 15 ’24, was worth 396,699. In this transaction President and Chief Executive of this company sold 33,848 shares at a rate of $11.72, taking the stock ownership to the 377,734 shares. Before that another transaction happened on Jul 15 ’24, when Company’s Chief Operating Officer sold 10,901 for $11.72, making the entire transaction worth $127,760. This insider now owns 240,421 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Latest Financial update
In its latest quarterly report, released on 3/31/2024, the company reported earnings of -0.84 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.79% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Here are Phathom Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 249.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.41, a number that is poised to hit -1.32 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.58 million. That was inferior than the volume of 0.74 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.38%. Additionally, its Average True Range was 0.82.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 64.52%, which indicates a significant increase from 28.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.31% in the past 14 days, which was lower than the 72.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.96, while its 200-day Moving Average is $9.35. However, in the short run, Phathom Pharmaceuticals Inc’s stock first resistance to watch stands at $11.41. Second resistance stands at $11.75. The third major resistance level sits at $12.23. If the price goes on to break the first support level at $10.59, it is likely to go to the next support level at $10.11. The third support level lies at $9.77 if the price breaches the second support level.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
With a market capitalization of 647.45 million, the company has a total of 58,535K Shares Outstanding. Currently, annual sales are 680 K while annual income is -201,590 K. The company’s previous quarter sales were 1,910 K while its latest quarter income was -82,850 K.
